COMMUNIQUÉS West-GlobeNewswire

-
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
14/06/2025 -
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
14/06/2025 -
Avricore Grants Options
14/06/2025 -
SAFE - Lancement d’une réduction de capital non motivée par des pertes par voie de réduction de la valeur nominale des actions sous condition suspensive de la réalisation des opérations de regroupement d’actions
14/06/2025 -
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025 -
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
13/06/2025 -
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2025 -
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
13/06/2025 -
MSP Recovery Law Firm Files Class Action Lawsuit Against Ralph Navarro and FYI Yachts for Alleged Fraud, Racketeering, and Consumer Abuse
13/06/2025 -
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
13/06/2025 -
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
13/06/2025 -
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
13/06/2025 -
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
13/06/2025 -
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
13/06/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2025
13/06/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
13/06/2025 -
Sunset Social Club Opens as West Hollywood’s First Luxury Cannabis Lounge for Members Only
13/06/2025 -
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
13/06/2025 -
ORLADEYO® (berotralstat) Approved in Colombia
13/06/2025
Pages